A new paradigm for classifying and treating HER2-positive breast cancer.

Xuexin He,Sai-Ching J Yeung,Francisco J Esteva

Cancer reports (Hoboken, N.J.)（2023）

引用 0|浏览5

暂无评分

摘要

It will assist clinicians in developing an optimal treatment regimen at the outset, curing more HER2+ BC patients and improving their quality of life.

查看译文

关键词

classification, cure, HER2-positive breast cancer, paradigm, treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要